Crescita Therapeutics Inc (TSX:CTX) Share Price

Company Profile

Business description
Crescita Therapeutics Inc is a commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The company has three reportable segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The firm generates its revenue from Commercial Skincare Product Sales in Canada followed by USA and Rest of the world.
Contact
2805, Place Louis-R-Renaud
LavalQCH7V 0A3
CAN
T: +1 800 361-0352
https://www.crescitatherapeutics.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
65

Recommended

Ongoing rate hikes have investors spooked.

Simonelle Mody | 21 May 2026

Mark and Shani run through lessons for ASX stocks, ETFs and LICs that have delivered over the past decade.

Shani Jayamanne | 21 May 2026

The first public financials from Elon Musk’s company highlight Starlink’s revenue power and increased spending on AI.

Michael Bodley | 21 May 2026

Index	Last price	Change	% Change
All Ordinaries	8,840.80	9.50	-0.11%
CAC 40	8,083.75	33.67	-0.41%
DAX 40	24,607.39	129.85	-0.52%
Dow JONES (US)	49,856.85	152.50	-0.30%
FTSE 100	10,409.99	22.35	-0.21%
HKSE	25,386.52	264.60	-1.03%
NASDAQ	26,270.36	399.65	1.54%
Nikkei 225	61,684.14	1,879.73	3.14%
NZX 50 Index	12,878.07	117.04	0.92%
S&P 500	7,402.31	30.66	-0.41%
S&P/ASX 200	8,621.70	6.30	-0.07%
SSE Composite Index	4,077.28	84.91	-2.04%